Angiogenesis inhibitor TNP-470 suppresses the progression of experimentally-induced hepatocellular carcinoma in rats.
Motoaki Kin(Kurume University), M Sata(Keio University), Takato Ueno(Kurume University), Tõru Nakamura, Masaharu Sakamoto(Kurume University), Riko Ogata(Kurume University), S. Tamaki(Kurume University), Takuji Torimura(Omuta hospital)
Cited by 41
Related Papers
Therapeutic effects of restricted diet and exercise in obese patients with fatty liver
|Journal of Hepatology|1997|614
Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update
|Hepatology Research|2019|539
Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review
|Journal of Hepatology|2016|504
MAFLD identifies patients with significant hepatic fibrosis better than NAFLD
|Liver International|2020|410